Target intelligence / Profile preview

PRAME family member 34, pseudogene (PRAMEF34P)

Target: PRAMEF34P
Molecular classification: Other (Pseudogene; PRAME family)

Overview

PRAME family member 34, pseudogene (PRAMEF34P) is classified as a pseudogene according to multiple genomic databases and nomenclature authorities[1][3]. It is part of the PRAME (Preferentially Expressed Antigen in Melanoma) gene family, whose functional members are associated with various biological processes and disease contexts, notably cancer. However, as a pseudogene, PRAMEF34P does not encode a functional protein, is not known to have biological functions, and is not considered a therapeutic target in drug development. No disease associations, biomarkers, drug interactions, or safety concerns are established for this entity. Its locus is on human chromosome 1[1][3].

Other names: PRAMEF34P

Beyond the preview

Go deeper on PRAME family member 34, pseudogene (PRAMEF34P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 34, pseudogene (PRAMEF34P).

Explore the full profile